Good Shepherd Medication Management
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 5,525,009 | 5,731,111 | −206,102 | -0.4 | 7% |
| 2018 | 6,166,210 | 6,155,036 | 11,174 | -0.4 | 5% |
| 2019 | 4,967,043 | 4,244,057 | 722,986 | 11.3 | 7% |
| 2020 | 2,559,042 | 4,738,043 | −2,179,001 | 4.6 | 2% |
| 2021 | 1,862,836 | 2,607,270 | −744,434 | 4.9 | 9% |
| 2022 | 2,347,722 | 3,175,618 | −827,896 | 0.9 | 5% |
| 2023 | 815,374 | 1,265,218 | −449,844 | -2.1 | 10% |
In its most recent public year (2023), this organization spent $449,844 more than it brought in. Its liabilities exceeded its net assets — reserves were below zero (-2.1 months), down from -0.4 in 2017. Staff pay was 10% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works